Sign is posted in front of the Gilead Sciences headquarters on April 29, 2020 in Foster City, California. Gilead Sciences announced preliminary...
Sign is posted in front of the Gilead Sciences headquarters on April 29, 2020 in Foster City, California. Gilead Sciences announced preliminary...
Gilead Sciences Inc.'s Truvada AIDS medication is arranged for a photo at Ansonia Pharmacy in New York, U.S., on Thursday, July 24, 2008. Gilead is...
Sign is posted in front of the Gilead Sciences headquarters on April 29, 2020 in Foster City, California. Gilead Sciences announced preliminary...
Sign is posted in front of the Gilead Sciences headquarters on April 29, 2020 in Foster City, California. Gilead Sciences announced preliminary...
Sign with logo for pharmaceutical company Gilead in the Silicon Valley, Foster City, California, April 11, 2020.
Daniel O'Day Chairman/CEO, Gilead Sciences Inc, arrives for "The Elizabeth Taylor Ball to End AIDS" at the West Hollywood Park, California, September...
Gilead Sciences headquarters sign is seen in Foster City, California on April 30, 2020. Gilead Science's remdesivir, one of the most highly...
Gilead Sciences headquarters sign is seen in Foster City, California on April 30, 2020. Gilead Science's remdesivir, one of the most highly...
The Gilead headquarters in Foster City, California, US, on Monday, Jan. 29, 2024. Gilead Sciences Inc. Is scheduled to release earnings figures on...
People visit the Gilead Sciences Inc. Booth during the 6th China International Import Expo at the National Exhibition and Convention Center on...
Darryl Kato, research scientist for Gilead Sciences Inc., works on the synthesis of a potential hepatitis C virus drug candidate at the company's lab...
An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. Lab in Foster City, California,...
The Gilead contingent walks during the 52nd annual San Francisco Pride Parade on June 26, 2022 in San Francisco, California. Thousands of people came...
Gilead Sciences logo displayed on a laptop screen and medical pills are seen in this illustration photo taken in Krakow, Poland on October 18, 2021.
In this photo illustration, the American biotechnology company Gilead Sciences logo is seen on an Android mobile device screen with the currency of...
Sign with logo for pharmaceutical company Gilead in the Silicon Valley, Foster City, California, April 11, 2020.
Gilead Sciences headquarters sign is seen in Foster City, California on April 30, 2020. Gilead Science's remdesivir, one of the most highly...
In this photo illustration a Gilead logo is displayed on a smartphone next to a screen showing a coronavirus graphic on March 25, 2020 in Arlington,...
The Gilead Sciences Inc. Sign is seen outside the company's headquarters in Foster City, California, on Thursday, March 29, 2007. Biotechnology...
Members of the association Act Up hold signs as they lay on the floor in front of a stand of US pharmaceutical giant Gilead Sciences to denounce the...
The Gilead headquarters in Foster City, California, US, on Monday, Jan. 29, 2024. Gilead Sciences Inc. Is scheduled to release earnings figures on...
The Gilead headquarters in Foster City, California, US, on Monday, Jan. 29, 2024. Gilead Sciences Inc. Is scheduled to release earnings figures on...
Frank Holland, CNBC Reporter, Deborah Telman, Executive Vice President of Corporate Affairs and General Counsel of Gilead Sciences, Inc and Daniel...
Daniel O'Day, Chairman and Chief Executive Officer of Gilead Sciences, Inc. Speaks during the Global Black Economic Forum's Access & Economic...
Darryl Kato, research scientist for Gilead Sciences Inc., works on the synthesis of a potential hepatitis C virus drug candidate at the company's lab...
In this photo illustration the American biotechnology company Gilead Sciences logo seen displayed on a smartphone with an economic stock exchange...
In this photo illustration the American biotechnology company Gilead Sciences logo seen displayed on a smartphone with the word cancelled on a...
In this photo illustration of the TradingView stock market chart of Gilead Sciences, Inc. Seen displayed on a smartphone with Gilead Sciences, Inc....
Illuminations on the facade of a Cracow building part of Together against HIV action organised by Fundacja Pomocy Humanitarnej Res Humanae and Gilead...
Vials of cancer testing cells are seen at the Gilead Sciences Inc. Laboratory in Foster City, California, U.S., on Wednesday, August 10, 2011. Gilead...
Maria Kovalenko, a scientist at Gilead Sciences Inc., analyzes patient antibody levels at the Gilead laboratory in Foster City, California, U.S., on...
Scott McCauley, an associate scientist at Gilead Sciences Inc., makes human proteins at the Gilead laboratory in Foster City, California, U.S., on...
Gilead Sciences headquarters are seen in Foster City, California on April 30, 2020. - Gilead Science's remdesivir, one of the most highly anticipated...
In this photo illustration a Gilead logo is displayed on a smartphone on March 25, 2020 in Arlington, Virginia. - Gilead announced on March 25, 2020...
Signage is displayed outside Gilead Sciences Inc. Headquarters in in Foster City, California, U.S., on Thursday, March 19, 2020. Gilead Sciences...
Daniel O'Day, CEO of Gilead Sciences, testifies before the House Committee on Oversight and Reform during a hearing on why its' HIV prevention drug,...
An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. Lab in Foster City, California,...
An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. Lab in Foster City, California,...
George Gates from Gilead Sciences attends the 2018 AIDS Walk New York on May 20, 2018 in New York City.
George Gates from Gilead Sciences attends the 2018 AIDS Walk New York on May 20, 2018 in New York City.
Man walks past Gilead Sciences Inc. Offices in Foster City, California on Monday, October 31, 2005. The firm developed Tamiflu, an antiviral drug...
Gilead Sciences Inc. Offices in Foster City, California are pictured on Monday, October 31, 2005. The firm developed Tamiflu, an antiviral drug...
Canadian geese walk past Gilead Sciences Inc. Offices in Foster City, California on Monday, October 31, 2005. The firm developed Tamiflu, an...
Gilead Sciences Inc.'s Truvada AIDS medication is arranged for a photo at Ansonia Pharmacy in New York, U.S., on Thursday, July 24, 2008. Gilead is...
Gilead Sciences Inc.'s Viread AIDS medication is arranged for a photo at Ansonia Pharmacy in New York, U.S., on Thursday, July 24, 2008. Gilead is...
Gilead Sciences Inc.'s Viread AIDS medication is arranged for a photo at Ansonia Pharmacy in New York, U.S., on Thursday, July 24, 2008. Gilead is...
Gilead Sciences Inc.'s Viread AIDS medication is arranged for a photo at Ansonia Pharmacy in New York, U.S., on Thursday, July 24, 2008. Gilead is...
Treatment Sustiva is shown in a Cambridge, Massachusetts pharmacy Wednesday, July 12, 2006. U.S. Regulators said they approved a once-a-day pill...
Treatment Sustiva is shown in a Cambridge, Massachusetts pharmacy Wednesday, July 12, 2006. U.S. Regulators said they approved a once-a-day pill...
Treatment Viread is shown in a Cambridge, Massachusetts pharmacy Wednesday, July 12, 2006. U.S. Regulators said they approved a once-a-day pill...
Bottles of AIDS treatments Sustiva, Viread, and Emtriva are shown in a Cambridge, Massachusetts pharmacy among Emtriva pills Wednesday, July 12,...
Treatment Viread is shown in a Cambridge, Massachusetts pharmacy Wednesday, July 12, 2006. U.S. Regulators said they approved a once-a-day pill...
Bottles of AIDS treatments Sustiva, Viread, and Emtriva are shown in a Cambridge, Massachusetts pharmacy among Emtriva pills Wednesday, July 12,...
People walk past a Genentech Inc. Sign in San Francisco, California, on Wednesday, March 29, 2007. Biotechnology companies including Genentech Inc....
Craig McClure, executive director of the International AIDS Society, attends a forum at the 4th International Aids Society Conference, in Sydney,...
Dr. Robert Bailey, professor of epidemiology at the University of Illinois, listens during a forum at the 4th International Aids Society Conference,...